Remote manufacturing assessments: FDA revises draft guidance to include newly expanded powers
The FDA on Friday released newly revised Q&A guidance on how the agency can use voluntary and mandatory remote regulatory assessments to better understand biopharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
